Cite
HARVARD Citation
Thummalapalli, R. et al. (2020). Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma. Leukemia & lymphoma. 61 (1), pp. 228-230. [Online].